• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于宏基因组学的系统分析表明,肠道微生物群中与Gd-IgA1相关的酶可能在IgA肾病中起关键作用。

Metagenomics-based systematic analysis reveals that gut microbiota Gd-IgA1-associated enzymes may play a key role in IgA nephropathy.

作者信息

Liang Xiaolin, Zhang Simeng, Zhang Difei, Hu Liang, Zhang La, Peng Yu, Xu Yuan, Hou Haijing, Zou Chuan, Liu Xusheng, Chen Yang, Lu Fuhua

机构信息

The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.

Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.

出版信息

Front Mol Biosci. 2022 Aug 24;9:970723. doi: 10.3389/fmolb.2022.970723. eCollection 2022.

DOI:10.3389/fmolb.2022.970723
PMID:36090029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9449366/
Abstract

IgA nephropathy (IgAN) is the most common type of glomerulonephritis in Asia. Its pathogenesis involves higher expression of galactose-deficient IgA1 (Gd-IgA1) and dysregulated intestinal mucosal immunity. The objective of this study was to explore whether specific gut microbiota and associated enzymes affect Gd-IgA1 in IgAN. This study carried out shotgun metagenomic sequencing with Illumina on fecal samples collected from 20 IgAN patients (IgAN group) and 20 healthy controls (HCs group) who were recruited from January 2016 to December 2018 at the Second Clinical College of Guangzhou University of Chinese Medicine. Differences analysis in gut microbiota was performed to determine the overall microbiota composition, the representative enterotypes, and the microbiota abundance. Correlations between gut microbiota and clinical indicators were assessed by Spearman's analysis. Moreover, the functional prediction of microbial communities and the quantitative calculation of enzymes encoded by microbiome were performed using the MetaCyc pathway and the bioBakery three platform, respectively. and levels were higher, while and levels were lower in the IgAN group compared to HCs group. Enterotype I characterized by was closely related to the IgAN patients. Moreover, , and were characteristic bacteria enriched in IgAN patients. Spearman's correlation analysis found that and were positively correlated with urine protein-creatinine ratio, while showed a direct association with red blood cells in urine, and and were positively correlated with eGFR. These results indicated that intestinal dysbacteriosis occurred in IgAN patients and was associated with clinical and biochemical features. In addition, MetaCyc pathway analysis predicted microbiota-related metabolic pathways, including the biosynthesis of amino acids and glycans, were associated with the IgAN group. Microbial enzymes analysis highlighted that Gd-IgA1-associated α-galactosidase and α-N-acetyl-galactosaminidase secreted by were enriched in IgAN patients. These findings suggested that α-galactosidase and α-N-acetyl-galactosaminidase secreted by might be related to the production of Gd-IgA1, indicating that enzymes originated from abnormal intestinal microbiota may contribute to the production of Gd-IgA1 and play an important role in the pathogenesis of IgAN.

摘要

IgA肾病(IgAN)是亚洲最常见的肾小球肾炎类型。其发病机制涉及半乳糖缺陷型IgA1(Gd-IgA1)表达升高和肠道黏膜免疫失调。本研究的目的是探讨特定肠道微生物群及相关酶是否影响IgAN中的Gd-IgA1。本研究对2016年1月至2018年12月在广州中医药大学第二临床医学院招募的20例IgA肾病患者(IgAN组)和20例健康对照者(HCs组)的粪便样本进行了Illumina鸟枪法宏基因组测序。进行肠道微生物群差异分析以确定总体微生物群组成、代表性肠型和微生物群丰度。通过Spearman分析评估肠道微生物群与临床指标之间的相关性。此外,分别使用MetaCyc途径和bioBakery三个平台对微生物群落进行功能预测和微生物组编码酶的定量计算。与HCs组相比,IgAN组的[具体指标1]和[具体指标2]水平较高,而[具体指标3]和[具体指标4]水平较低。以[具体细菌名称]为特征的肠型I与IgAN患者密切相关。此外,[具体细菌名称1]、[具体细菌名称2]和[具体细菌名称]是IgAN患者中富集特征性细菌。Spearman相关性分析发现,[具体细菌名称1]和[具体细菌名称2]与尿蛋白肌酐比值呈正相关,而[具体细菌名称3]与尿红细胞呈直接关联,[具体细菌名称4]和[具体细菌名称5]与估算肾小球滤过率(eGFR)呈正相关。这些结果表明IgAN患者存在肠道菌群失调,且与临床和生化特征相关。此外,MetaCyc途径分析预测微生物群相关代谢途径,包括氨基酸和聚糖的生物合成,与IgAN组相关。微生物酶分析强调,IgAN患者中富集了由[具体细菌名称]分泌的与Gd-IgA1相关的α-半乳糖苷酶和α-N-乙酰半乳糖胺酶。这些发现表明,由[具体细菌名称]分泌的α-半乳糖苷酶和α-N-乙酰半乳糖胺酶可能与Gd-IgA1的产生有关,表明源自异常肠道微生物群的酶可能有助于Gd-IgA1的产生,并在IgAN的发病机制中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/5f4c4f947ce2/fmolb-09-970723-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/533da90fb0bc/fmolb-09-970723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/3c66306a7ae6/fmolb-09-970723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/45291edab7e8/fmolb-09-970723-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/92b9152d5d34/fmolb-09-970723-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/c53770949341/fmolb-09-970723-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/4fa7c4269d68/fmolb-09-970723-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/5f4c4f947ce2/fmolb-09-970723-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/533da90fb0bc/fmolb-09-970723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/3c66306a7ae6/fmolb-09-970723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/45291edab7e8/fmolb-09-970723-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/92b9152d5d34/fmolb-09-970723-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/c53770949341/fmolb-09-970723-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/4fa7c4269d68/fmolb-09-970723-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be9/9449366/5f4c4f947ce2/fmolb-09-970723-g007.jpg

相似文献

1
Metagenomics-based systematic analysis reveals that gut microbiota Gd-IgA1-associated enzymes may play a key role in IgA nephropathy.基于宏基因组学的系统分析表明,肠道微生物群中与Gd-IgA1相关的酶可能在IgA肾病中起关键作用。
Front Mol Biosci. 2022 Aug 24;9:970723. doi: 10.3389/fmolb.2022.970723. eCollection 2022.
2
IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway.IgA 肾病:肠道微生物组通过 TLR4 信号通路调节低糖化 IgA1 的产生。
Nephrol Dial Transplant. 2024 Sep 27;39(10):1624-1641. doi: 10.1093/ndt/gfae052.
3
Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population.肠道微生物群的改变与中国人群 IgA 肾病的严重程度相关。
Int Immunopharmacol. 2020 Dec;89(Pt B):107085. doi: 10.1016/j.intimp.2020.107085. Epub 2020 Oct 14.
4
Gut Dysbiosis and Intestinal Barrier Dysfunction Promotes IgA Nephropathy by Increasing the Production of Gd-IgA1.肠道微生物群失调和肠道屏障功能障碍通过增加Gd-IgA1的产生促进IgA肾病。
Front Med (Lausanne). 2022 Jul 7;9:944027. doi: 10.3389/fmed.2022.944027. eCollection 2022.
5
Aberrant Gut Microbiome Contributes to Barrier Dysfunction, Inflammation, and Local Immune Responses in IgA Nephropathy.肠道微生物组异常导致 IgA 肾病的屏障功能障碍、炎症和局部免疫反应。
Kidney Blood Press Res. 2023;48(1):261-276. doi: 10.1159/000528973. Epub 2023 Mar 6.
6
Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.血清半乳糖缺乏 IgA 水平在 IgA 肾病患者中升高,但与疾病活动或进展无关。
BMC Nephrol. 2023 Jun 7;24(1):160. doi: 10.1186/s12882-023-03198-y.
7
Mechanism of Yiqi Yangying Heluo Formula in the Treatment of IgA Nephropathy by Affecting Gd-IgA1 Based on BAFF Molecular Level and T Lymphocyte Immunity.基于 BAFF 分子水平和 T 淋巴细胞免疫探讨益气养营河洛方治疗 IgA 肾病的作用机制。
Biomed Res Int. 2023 Jan 10;2023:5124034. doi: 10.1155/2023/5124034. eCollection 2023.
8
Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.IgA 肾病中异常表达的 mRNA 谱的综合分析及其与血清半乳糖缺陷 IgA1 水平的关系。
J Transl Med. 2019 Sep 23;17(1):320. doi: 10.1186/s12967-019-2064-3.
9
Humoral immune responses primed by the alteration of gut microbiota were associated with galactose-deficient IgA1 production in IgA nephropathy.肠道微生物群改变引发的体液免疫应答与 IgA 肾病中半乳糖缺乏 IgA1 的产生有关。
Front Immunol. 2024 Jul 22;15:1415026. doi: 10.3389/fimmu.2024.1415026. eCollection 2024.
10
Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.血清半乳糖缺乏 IgA1 水平对 IgA 肾病患儿的临床意义。
J Immunol Res. 2020 May 21;2020:4284379. doi: 10.1155/2020/4284379. eCollection 2020.

引用本文的文献

1
The impact of climate, weather, seasonal transitions, and diurnal rhythms on gut microbiota and immune homeostasis.气候、天气、季节转换和昼夜节律对肠道微生物群和免疫稳态的影响。
Antonie Van Leeuwenhoek. 2025 Jun 1;118(7):86. doi: 10.1007/s10482-025-02097-6.
2
Gut Microbiota and Immunoglobulin A Nephropathy: Exploration of Dietary Intervention and Treatment Strategies.肠道微生物群与免疫球蛋白A肾病:饮食干预及治疗策略探索
Food Sci Nutr. 2025 May 1;13(5):e70218. doi: 10.1002/fsn3.70218. eCollection 2025 May.
3
Characteristics of Intestinal Flora in Patients With Schistosoma japonicum Infection Undergoing Splenectomy.

本文引用的文献

1
Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.IgA 肾病患者循环中缺乏半乳糖的 IgA1 B 细胞优先携带 λ 轻链和黏膜归巢受体。
J Am Soc Nephrol. 2022 May;33(5):908-917. doi: 10.1681/ASN.2021081086. Epub 2022 Feb 3.
2
Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney link.IgA 肾病的免疫发病机制:探索黏膜-肾脏联系。
Int J Immunogenet. 2022 Feb;49(1):8-21. doi: 10.1111/iji.12561. Epub 2021 Nov 24.
3
Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don't Know.
日本血吸虫感染患者脾切除术后肠道菌群特征
Parasite Immunol. 2025 May;47(5):e70008. doi: 10.1111/pim.70008.
4
Characteristics, pathogenic and therapeutic role of gut microbiota in immunoglobulin A nephropathy.肠道微生物群在免疫球蛋白A肾病中的特征、致病作用及治疗作用
Front Immunol. 2025 Feb 6;16:1438683. doi: 10.3389/fimmu.2025.1438683. eCollection 2025.
5
The evolving understanding of systemic mechanisms in organ-specific IgA nephropathy: a focus on gut-kidney crosstalk.对器官特异性IgA肾病全身机制的不断演变的认识:聚焦于肠-肾相互作用。
Theranostics. 2025 Jan 1;15(2):656-681. doi: 10.7150/thno.104631. eCollection 2025.
6
Association between the Maternal Gut Microbiome and Macrosomia.母体肠道微生物群与巨大儿之间的关联。
Biology (Basel). 2024 Jul 28;13(8):570. doi: 10.3390/biology13080570.
7
Advancements in understanding the role of intestinal dysbacteriosis mediated mucosal immunity in IgA nephropathy.深入了解肠道菌群失调介导的黏膜免疫在 IgA 肾病中的作用。
BMC Nephrol. 2024 Jun 21;25(1):203. doi: 10.1186/s12882-024-03646-3.
IgA肾病中糖基化异常的IgA1:我们所知道的和未知的
J Clin Med. 2021 Aug 5;10(16):3467. doi: 10.3390/jcm10163467.
4
Prevotella diversity, niches and interactions with the human host.普雷沃氏菌多样性、生态位及其与人类宿主的相互作用。
Nat Rev Microbiol. 2021 Sep;19(9):585-599. doi: 10.1038/s41579-021-00559-y. Epub 2021 May 28.
5
Flavonifractor plautii bloodstream infection in an asplenic patient with infectious colitis.贫血真杆菌血流感染伴感染性结肠炎的无脾患者。
Wien Klin Wochenschr. 2021 Jul;133(13-14):724-726. doi: 10.1007/s00508-021-01877-0. Epub 2021 May 27.
6
Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3.利用 bioBakery 3 整合具有分类学、功能和菌株水平特征的多样化微生物群落。
Elife. 2021 May 4;10:e65088. doi: 10.7554/eLife.65088.
7
Diversity and dynamism of IgA-microbiota interactions.IgA 与微生物群相互作用的多样性和动态性。
Nat Rev Immunol. 2021 Aug;21(8):514-525. doi: 10.1038/s41577-021-00506-1. Epub 2021 Feb 10.
8
Gut species in health and disease.肠道物种在健康和疾病中的作用。
Gut Microbes. 2021 Jan-Dec;13(1):1-20. doi: 10.1080/19490976.2020.1848158.
9
Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals.1098 名深度表型个体的微生物组与宿主代谢和习惯性饮食的关联。
Nat Med. 2021 Feb;27(2):321-332. doi: 10.1038/s41591-020-01183-8. Epub 2021 Jan 11.
10
Alterations of the Human Gut Microbiome in Chronic Kidney Disease.慢性肾脏病患者肠道微生物群的改变
Adv Sci (Weinh). 2020 Sep 2;7(20):2001936. doi: 10.1002/advs.202001936. eCollection 2020 Oct.